Seqens Seqens

X

Find Radio Compass News for Tox21_202591

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-13-2024-4844.pdf

FDA
13 Mar 2024

https://www.reuters.com/article/us-iran-nuclear-drugs/u-s-sanctions-on-iran-threaten-access-to-certain-medicines-report-idUSKBN1X82IM?feedType=RSS&feedName=healthNews

P. Aripaka REUTERS
30 Oct 2019

https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

Angus Liu FIERCE PHARMA
21 Jun 2019

http://www.pmlive.com/pharma_news/italian_pharma_scandals_prompts_call_for_eu-wide_pricing_probe_1168682

Phil Taylor PMLIVE
19 Oct 2016

http://www.prnewswire.com/news-releases/inherited-gene-variation-helps-explain-drug-toxicity-in-patients-of-east-asian-ancestry-300025942.html

PR NEWSWIRE
26 Jan 2015

http://www.pmlive.com/pharma_news/nice_backs_three_ulcerative_colitis_treatments_625463

EXTERNAL LINK PMLiVE
20 Dec 2014
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY